2019
DOI: 10.1080/17460441.2019.1575360
|View full text |Cite
|
Sign up to set email alerts
|

Animal models of major depressive disorder and the implications for drug discovery and development

Abstract: Depression is a highly debilitating syndrome that affects the global population and is associated with disabilities and suicide. Depression remains poorly studied and is often treatment resistant and recurrent. Thus, development of new therapies and drugs is needed in the field. Animal models are indispensable for translational biological psychiatry, and may advance the study of depression. While poor understating of psychiatric disorders (including depression) is slowing down further progress in the field, no… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
16
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 17 publications
(16 citation statements)
references
References 306 publications
(237 reference statements)
0
16
0
Order By: Relevance
“…The model might be particularly useful in the preclinical phase to test whether a particular drug/treatment is effective in preventing affective and behavioral changes in endotoxin-challenged healthy humans. This would nicely complement animal studies (e.g., [ 100 102 , 114 116 ]), by developing tailored therapies for patients with inflammation-associated depression, and testing them in a human population free of comorbidities and in a limited period of time.…”
Section: Experimental Endotoxemia As a Tool To Develop And Test Therapies For Inflammation-associated Depressionmentioning
confidence: 99%
“…The model might be particularly useful in the preclinical phase to test whether a particular drug/treatment is effective in preventing affective and behavioral changes in endotoxin-challenged healthy humans. This would nicely complement animal studies (e.g., [ 100 102 , 114 116 ]), by developing tailored therapies for patients with inflammation-associated depression, and testing them in a human population free of comorbidities and in a limited period of time.…”
Section: Experimental Endotoxemia As a Tool To Develop And Test Therapies For Inflammation-associated Depressionmentioning
confidence: 99%
“…In general, to better understand human emotional disorders, we may need to target not only specific individual phenotypes of interest, but also their neural aspects, such as neurochemistry or circuitry (Demin et al, ). Because no animal is a perfect replication of the human emotional landscape, not all criteria can be met by a single model of affective behavior (Demin et al, ). Thus, using a combination of different model organisms (e.g., rodents, zebrafish and crayfish) may improve our understanding of each specific emotional condition.…”
Section: Resultsmentioning
confidence: 99%
“…These findings could be successfully supported in LL characterized alert behavior with Ecall and Shake as shown in our BOUQUET visualization and the reduction of higher local preference, whose meanings might be assumed as "depressive" with potential energy restriction. Animal model studies of depression have contributed to reveal pathogenesis and the development of multidirectional treatment strategies (Demin et al, 2019). Traumatic life experiences induces dysregulation in the hypothalamic-pituitary-adrenal (HPA) axis with cortisol and the locus caeruleus/norepinephrine-sympathetic nervous system (LC/NE-SNS) when the immune system activates (Pervanidou and Chrousos, 2012).…”
Section: Discussionmentioning
confidence: 99%